Table 4.
Oxytocin | Placebo | |||||||
---|---|---|---|---|---|---|---|---|
Outcome Variablea | Time Point (wks) |
N | LS Mean (SE) |
P-Valueb Diff>0 |
N | LS Mean (SE) |
P-Valueb Diff>0 |
P-Valuec Trt Diff |
PANSS Total | 2 | 32 | −4.10 (1.35) |
0.004 | 30 | −6.13 (1.40) |
0.000 | 0.310 |
6 | 28 | −3.23 (1.49) |
0.035 | 29 | −5.56 (1.49) |
0.000 | 0.279 | |
9 | 27 | −4.21 (1.69) |
0.016 | 29 | −4.77 (1.65) |
0.006 | 0.815 | |
12 | 26 | −3.54 (1.60) |
0.032 | 29 | −5.49 (1.54) |
0.001 | 0.389 | |
PANSS Positive | 2 | 32 | −1.21 (0.43) |
0.007 | 30 | −1.40 (0.45) |
0.003 | 0.774 |
6 | 28 | −0.59 (0.55) |
0.292 | 29 | −1.68 (0.55) |
0.003 | 0.168 | |
9 | 27 | −1.39 (0.60) |
0.025 | 29 | −1.50 (0.59) |
0.014 | 0.894 | |
12 | 26 | −1.10 (0.56) |
0.056 | 29 | −1.49 (0.54) |
0.008 | 0.614 | |
PANSS Negative | 2 | 32 | −1.20 (0.52) |
0.024 | 30 | −0.65 (0.54) |
0.232 | 0.467 |
6 | 28 | −1.28 (0.62) |
0.044 | 29 | −0.36 (0.62) |
0.558 | 0.303 | |
9 | 27 | −0.92 (0.55) |
0.099 | 29 | −0.13 (0.54) |
0.816 | 0.309 | |
12 | 26 | −1.18 (0.59) |
0.051 | 29 | −0.64 (0.57) |
0.261 | 0.521 | |
PANSS General | 2 | 32 | −1.76 (0.84) |
0.042 | 30 | −4.02 (0.88) |
0.000 | 0.071 |
6 | 28 | −1.41 (0.79) |
0.077 | 29 | −3.46 (0.79) |
0.000 | 0.076 | |
9 | 27 | −1.92 (1.10) |
0.087 | 29 | −3.08 (1.08) |
0.006 | 0.460 | |
12 | 26 | −1.44 (0.93) |
0.127 | 29 | −3.28 (0.89) |
0.001 | 0.164 |
Abbreviations: LS, least squares; PANSS, Positive and Negative Syndrome Scale
Models adjusted for baseline value and age in addition to treatment group.
Test for within-group change
Test for between-group change